For the quarter ended December 2023, Axon Enterprise (AXON - Free Report) reported revenue of $432.14 million, up 28.6% over the same period last year. EPS came in at $1.12, compared to $0.70 in the year-ago quarter.
The reported revenue represents a surprise of +3.14% over the Zacks Consensus Estimate of $418.97 million. With the consensus EPS estimate being $0.86, the EPS surprise was +30.23%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Axon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Annual recurring revenue: $697 versus $657.86 estimated by two analysts on average.
- Revenue- TASER: $161.34 million versus the five-analyst average estimate of $160.58 million.
- Net Sales- Software and Sensors: $270.80 million versus the five-analyst average estimate of $258.39 million.
- Net Sales- Services- Software and Sensors: $163.63 million compared to the $156.23 million average estimate based on five analysts.
- Net Sales- Products- Software and Sensors: $107.17 million compared to the $102.16 million average estimate based on five analysts.
- Net Sales- Products: $258.41 million versus the four-analyst average estimate of $251.50 million.
- Net Sales- Products- TASER: $151.24 million versus $150 million estimated by four analysts on average.
- Net Sales- Services: $173.74 million versus $169.93 million estimated by three analysts on average.
- Net Sales- Services- TASER: $10.11 million versus the three-analyst average estimate of $10.22 million.
- Net Sales- Products- TASER- Extended warranties: $8.23 million versus the two-analyst average estimate of $7.54 million.
- Net Sales- Products- TASER- Other: $4.47 million compared to the $4.64 million average estimate based on two analysts.
- Net sales by Product- Software and Sensors segment- Axon Body: $58.96 million versus $51.97 million estimated by two analysts on average.
View all Key Company Metrics for Axon here>>>Shares of Axon have returned +6.6% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Just Released: Zacks Top 10 Stocks for 2024
Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.
See New Top 10 Stocks >>
For the quarter ended December 2023, Axon Enterprise (AXON - Free Report) reported revenue of $432.14 million, up 28.6% over the same period last year. EPS came in at $1.12, compared to $0.70 in the year-ago quarter.
The reported revenue represents a surprise of +3.14% over the Zacks Consensus Estimate of $418.97 million. With the consensus EPS estimate being $0.86, the EPS surprise was +30.23%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Axon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Annual recurring revenue: $697 versus $657.86 estimated by two analysts on average.
- Revenue- TASER: $161.34 million versus the five-analyst average estimate of $160.58 million.
- Net Sales- Software and Sensors: $270.80 million versus the five-analyst average estimate of $258.39 million.
- Net Sales- Services- Software and Sensors: $163.63 million compared to the $156.23 million average estimate based on five analysts.
- Net Sales- Products- Software and Sensors: $107.17 million compared to the $102.16 million average estimate based on five analysts.
- Net Sales- Products: $258.41 million versus the four-analyst average estimate of $251.50 million.
- Net Sales- Products- TASER: $151.24 million versus $150 million estimated by four analysts on average.
- Net Sales- Services: $173.74 million versus $169.93 million estimated by three analysts on average.
- Net Sales- Services- TASER: $10.11 million versus the three-analyst average estimate of $10.22 million.
- Net Sales- Products- TASER- Extended warranties: $8.23 million versus the two-analyst average estimate of $7.54 million.
- Net Sales- Products- TASER- Other: $4.47 million compared to the $4.64 million average estimate based on two analysts.
- Net sales by Product- Software and Sensors segment- Axon Body: $58.96 million versus $51.97 million estimated by two analysts on average.
View all Key Company Metrics for Axon here>>>Shares of Axon have returned +6.6% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Just Released: Zacks Top 10 Stocks for 2024
Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.
See New Top 10 Stocks >>
Get the latest research report on AXON - FREE